Insulin-like growth factor-I and growth differentiation factor-5 promote the formation of tissue-engineered human nasal septal cartilage
- PMID: 20178406
- PMCID: PMC2943402
- DOI: 10.1089/ten.TEC.2009.0396
Insulin-like growth factor-I and growth differentiation factor-5 promote the formation of tissue-engineered human nasal septal cartilage
Abstract
Introduction: Tissue engineering of human nasal septal chondrocytes offers the potential to create large quantities of autologous material for use in reconstructive surgery of the head and neck. Culture with recombinant human growth factors may improve the biochemical and biomechanical properties of engineered tissue. The objectives of this study were to (1) perform a high-throughput screen to assess multiple combinations of growth factors and (2) perform more detailed testing of candidates identified in part I.
Methods: In part I, human nasal septal chondrocytes from three donors were expanded in monolayer with pooled human serum (HS). Cells were then embedded in alginate beads for 2 weeks of culture in medium supplemented with 2% or 10% HS and 1 of 90 different growth factor combinations. Combinations of insulin-like growth factor-I (IGF-1), bone morphogenetic protein (BMP)-2, BMP-7, BMP-13, growth differentiation factor-5 (GDF-5), transforming growth factor β (TGFβ)-2, insulin, and dexamethasone were evaluated. Glycosaminoglycan (GAG) accumulation was measured. A combination of IGF-1 and GDF-5 was selected for further testing based on the results of part I. Chondrocytes from four donors underwent expansion followed by three-dimensional alginate culture for 2 weeks in medium supplemented with 2% or 10% HS with or without IGF-1 and GDF-5. Chondrocytes and their associated matrix were then recovered and cultured for 4 weeks in 12 mm transwells in medium supplemented with 2% or 10% HS with or without IGF-1 and GDF-5 (the same medium used for alginate culture). Biochemical and biomechanical properties of the neocartilage were measured.
Results: In part I, GAG accumulation was highest for growth factor combinations including both IGF-1 and GDF-5. In part II, the addition of IGF-1 and GDF-5 to 2% HS resulted in a 12-fold increase in construct thickness compared with 2% HS alone (p < 0.0001). GAG and type II collagen accumulation was significantly higher with IGF-1 and GDF-5. Confined compression modulus was greatest with 2% HS, IGF-1, and GDF-5.
Conclusion: Supplementation of medium with IGF-1 and GDF-5 during creation of neocartilage constructs results in increased accumulation of GAG and type II collagen and improved biomechanical properties compared with constructs created without the growth factors.
Figures





Similar articles
-
Human serum for tissue engineering of human nasal septal cartilage.Otolaryngol Head Neck Surg. 2006 Sep;135(3):397-403. doi: 10.1016/j.otohns.2006.05.029. Otolaryngol Head Neck Surg. 2006. PMID: 16949971
-
Tissue-engineered human nasal septal cartilage using the alginate-recovered-chondrocyte method.Laryngoscope. 2004 Jan;114(1):38-45. doi: 10.1097/00005537-200401000-00006. Laryngoscope. 2004. PMID: 14709992
-
Effect of growth factors on cell proliferation, matrix deposition, and morphology of human nasal septal chondrocytes cultured in monolayer.Laryngoscope. 2005 Sep;115(9):1553-60. doi: 10.1097/01.MLG.0000175541.31131.A5. Laryngoscope. 2005. PMID: 16148694 Clinical Trial.
-
Tissue engineering with chondrocytes.Facial Plast Surg. 2002 Feb;18(1):59-68. doi: 10.1055/s-2002-19828. Facial Plast Surg. 2002. PMID: 11823934 Review.
-
Tissue-engineered cartilage for facial plastic surgery.Curr Opin Otolaryngol Head Neck Surg. 2014 Aug;22(4):300-6. doi: 10.1097/MOO.0000000000000068. Curr Opin Otolaryngol Head Neck Surg. 2014. PMID: 24874211 Review.
Cited by
-
A compositional analysis of cadaveric human nasal septal cartilage.Laryngoscope. 2013 Sep;123(9):2120-4. doi: 10.1002/lary.23727. Epub 2013 Jul 2. Laryngoscope. 2013. PMID: 23821477 Free PMC article.
-
Effect of oxygen tension on tissue-engineered human nasal septal chondrocytes.Allergy Rhinol (Providence). 2014 Jan;5(3):125-31. doi: 10.2500/ar.2014.5.0097. Allergy Rhinol (Providence). 2014. PMID: 25565047 Free PMC article.
-
Sequential use of human-derived medium supplements favours cardiovascular tissue engineering.J Cell Mol Med. 2012 Apr;16(4):730-9. doi: 10.1111/j.1582-4934.2011.01351.x. J Cell Mol Med. 2012. PMID: 21645237 Free PMC article.
-
In vivo implantation of tissue-engineered human nasal septal neocartilage constructs: a pilot study.Otolaryngol Head Neck Surg. 2012 Jan;146(1):46-52. doi: 10.1177/0194599811425141. Epub 2011 Oct 26. Otolaryngol Head Neck Surg. 2012. PMID: 22031592 Free PMC article.
-
Shape fidelity of native and engineered human nasal septal cartilage.Otolaryngol Head Neck Surg. 2013 May;148(5):753-7. doi: 10.1177/0194599813478921. Epub 2013 Feb 20. Otolaryngol Head Neck Surg. 2013. PMID: 23426709 Free PMC article.
References
-
- von der Mark K. Gauss V. von der Mark H. Muller P. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature. 1977;267:531. - PubMed
-
- Homicz M.R. Schumacher B.L. Sah R.L. Watson D. Effects of serial expansion of septal chondrocytes on tissue-engineered neocartilage composition. Otolaryngol Head Neck Surg. 2002;127:398. - PubMed
-
- Homicz M.R. Chia S.H. Schumacher B.L. Masuda K. Thonar E.J. Sah R.L. Watson D. Human septal chondrocyte redifferentiation in alginate, polyglycolic acid scaffold, and monolayer culture. Laryngoscope. 2003;113:25. - PubMed
-
- Benya P.D. Shaffer J.D. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell. 1982;30:215. - PubMed
-
- Chia S.H. Schumacher B.L. Klein T.J. Thonar E.J. Masuda K. Sah R.L. Watson D. Tissue-engineered human nasal septal cartilage using the alginate-recovered-chondrocyte method. Laryngoscope. 2004;114:38. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous